These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3063500)

  • 1. Assessment of the risk-benefit ratio for antiarrhythmic drug use.
    Campbell RW
    Drugs; 1988 Nov; 36(5):616-32. PubMed ID: 3063500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-benefit profiles of antiarrhythmic therapy.
    Campbell RW; Nimkhedkar K
    Am J Cardiol; 1989 Dec; 64(20):50J-52J. PubMed ID: 2480709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of antiarrhythmic agents.
    Morganroth J
    Drugs; 1985; 29 Suppl 4():14-20. PubMed ID: 2861076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and treatment of ventricular arrhythmias: an update.
    McCollam PL; Parker RB
    Clin Pharm; 1991 Mar; 10(3):195-205. PubMed ID: 2040126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of and future perspectives on antiarrhythmic drugs.
    Estrada JC; Darbar D
    Eur J Clin Pharmacol; 2008 Dec; 64(12):1139-46. PubMed ID: 18762931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study].
    Meinertz T; Zehender M; Hohnloser SH
    Z Kardiol; 1992; 81 Suppl 4():145-9. PubMed ID: 1290291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic therapy for ventricular arrhythmias.
    Zimmermann M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S59-64. PubMed ID: 1723121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA; Vincent AC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antiarrhythmic drugs.
    Nestico PF; Morganroth J; Horowitz LN
    Drugs; 1988 Mar; 35(3):286-319. PubMed ID: 3286214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of ventricular arrhythmias: then and now.
    Bennett B; Singh S
    Am J Crit Care; 1992 Nov; 1(3):107-14. PubMed ID: 1307899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer antiarrhythmic drugs.
    Schmidt SB; Morgan DZ; Jain AC
    W V Med J; 1986 Nov; 82(11):433-5. PubMed ID: 3466475
    [No Abstract]   [Full Text] [Related]  

  • 13. The proarrhythmic effects of antiarrhythmic drugs.
    Creamer JE; Nathan AW; Camm AJ
    Am Heart J; 1987 Aug; 114(2):397-406. PubMed ID: 3604898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular arrhythmias, Part III: Benefits and risks of antiarrhythmic therapy.
    Grauer K; Gums J
    J Am Board Fam Pract; 1988; 1(4):255-66. PubMed ID: 3066124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic management of arrhythmias in patients with congenital heart disease.
    Batra AS; Luna CF; Silka MJ
    Am J Cardiovasc Drugs; 2001; 1(2):91-103. PubMed ID: 14728039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on new antiarrhythmic drugs.
    Morton PG
    Crit Care Nurs Clin North Am; 1994 Mar; 6(1):69-83. PubMed ID: 8192885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and toxicity of antiarrhythmic drug therapy: benefit versus risk.
    Podrid PJ
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S65-73. PubMed ID: 1723122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic drug selection.
    Podrid PJ
    Annu Rev Med; 1987; 38():1-17. PubMed ID: 3555284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A benefit-risk assessment of class III antiarrhythmic agents.
    Brendorp B; Pedersen O; Torp-Pedersen C; Sahebzadah N; Køber L
    Drug Saf; 2002; 25(12):847-65. PubMed ID: 12241126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.